Aaron Handler

Aaron Handler is a biotechnology leader with over 18 years of experience, currently serving as the CMC Program Lead for Cell Therapies at Takeda. In this role, they collaborate with cross-functional teams to guide CMC programs from pre-clinical to clinical stages, ensuring alignment with regulatory standards and organizational goals. Previously, they held significant positions at companies including Sanofi Genzyme, Cell Signaling Technology, and SQZ Biotechnologies, where they contributed to analytical development, quality control, and product marketing. Aaron earned a Ph.D. in Molecular and Cell Biology from Harvard University and a B.S. in Microbiology and Molecular Genetics from UCLA.